13F HOLDINGS REPORT
Stonepine Capital Management, LLC
Quarter ended Q2 2023 · Filed May 12, 2023 · Accession 0000935836-23-000397
Total Value
$298.2M
Positions
22
Other Managers
0
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AMRYT PHARMA PLC - SPNR ADR | 03217L106 | 6,278,085 | $91.5M | 30.70% |
| 2 | GALAPAGOS NV-SPON ADR | GLPGF | 782,289 | $30.2M | 10.14% |
| 3 | CTI BIOPHARMA CORP | 12648L601 | 6,535,674 | $27.4M | 9.21% |
| 4 | ADMA BIOLOGICS INC | ADMA | 7,661,690 | $25.4M | 8.51% |
| 5 | QUIDELORTHO CORP | QDEL | 279,081 | $24.9M | 8.34% |
| 6 | XERIS BIOPHARMA HOLDINGS INC | XERS | 8,640,205 | $14.1M | 4.72% |
| 7 | MAXCYTE INC | MXCT | 2,707,090 | $13.4M | 4.49% |
| 8 | THIRD HARMONIC BIO INC | 88427A107 | 3,131,995 | $12.9M | 4.33% |
| 9 | ATYR PHARMA INC | ATYR | 4,825,722 | $10.1M | 3.40% |
| 10 | XOMA CORP | XOMAP | 318,096 | $6.7M | 2.25% |
| 11 | CASTLE BIOSCIENCES INC | CSTL | 292,866 | $6.7M | 2.23% |
| 12 | UROGEN PHARMA LTD | URGN | 701,535 | $6.5M | 2.17% |
| 13 | REZOLUTE INC | RZLT | 3,087,649 | $5.9M | 1.99% |
| 14 | EVOLUS INC | EOLS | 578,795 | $4.9M | 1.64% |
| 15 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 416,519 | $4.1M | 1.37% |
| 16 | APOLLO ENDOSURGERY INC | 03767D108 | 370,000 | $3.7M | 1.23% |
| 17 | TRAVERE THERAPEUTICS INC | TVTX | 132,005 | $3.0M | 1.00% |
| 18 | EXAGEN INC | XGN | 1,037,074 | $2.5M | 0.85% |
| 19 | ATEA PHARMACEUTICALS INC | AVIR | 684,508 | $2.3M | 0.77% |
| 20 | SCYNEXIS INC | SCYX | 450,000 | $1.4M | 0.45% |
| 21 | CONFORMIS INC | 20717E200 | 402,651 | $648,268 | 0.22% |
| 22 | CIDARA THERAPEUTICS INC | 171757107 | 1,000 | $1,270 | 0.00% |